Denise Corti

发表

GSH-targeted nanosponges increase doxorubicin-induced toxicity "in vitro" and "in vivo" in cancer cells with high antioxidant defenses.

R. Cavalli, F. Trotta, M. Argenziano, 2016, Free radical biology & medicine.

Tumors and mitochondrial respiration: a neglected connection.

Andrea Viale, G. Draetta, A. Viale, 2015, Cancer research.

In Vivo Functional Platform Targeting Patient-Derived Xenografts Identifies WDR5-Myc Association as a Critical Determinant of Pancreatic Cancer.

Parantu K. Shah, Nora S. Sanchez, L. Chin, 2016, Cell reports.

Pre-existing Functional Heterogeneity of Tumorigenic Compartment as the Origin of Chemoresistance in Pancreatic Tumors.

Shan Jiang, Andrew Futreal, Andrea Viale, 2019, Cell reports.

Epithelial memory of inflammation limits tissue damage while promoting pancreatic tumorigenesis

G. Natoli, A. Maitra, Shaojun Zhang, 2021, Science.

Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer

L. Chin, L. Wood, R. DePinho, 2017, Nature.

The effects of CA IX catalysis products within tumor microenvironment

S. Serni, P. Paoli, P. Cirri, 2013, Cell Communication and Signaling.

Genetic events that limit the efficacy of MEK and RTK inhibitor therapies in a mouse model of KRAS-driven pancreatic cancer.

Parantu K. Shah, Nora S. Sanchez, G. Mills, 2015, Cancer research.

The "click-on-tube" approach for the production of efficient drug carriers based on oxidized multi-walled carbon nanotubes.

E. Giannoni, P. Paoli, P. Chiarugi, 2016, Journal of materials chemistry. B.

GSH-targeted nanosponges increase doxorubicin-induced toxicity "in vitro" and "in vivo" in cancer cells with high antioxidant defenses.

R. Cavalli, F. Trotta, M. Argenziano, 2016, Free radical biology & medicine.

Clonal dominance defines metastatic dissemination in pancreatic cancer.

G. Genovese, T. Heffernan, H. Ying, 2024, Science advances.